LETERCOR: Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir. (clinicaltrials.gov) - Mar 26, 2026 - P2 | N=90 | Recruiting | Sponsor: Maimónides Biomedical Research Institute of Córdoba | Active, not recruiting ➔ Recruiting
Enrollment open • Cytomegalovirus Infection • Infectious Disease • Neutropenia • Respiratory Diseases • Transplantation
|